Preparticipation cardiac screening in athletes: still a diamond in the rough? - Scorecard - MDSpire

Preparticipation cardiac screening in athletes: still a diamond in the rough?

  • By

  • Aaron Baggish

  • October 14, 2025

  • 0 min

Share

Clinical Scorecard: Evaluating the Role of Cardiac Screening Before Athletic Participation: An Untapped Opportunity?

At a Glance

CategoryDetail
ConditionUnderlying cardiovascular disease in competitive athletes
Key MechanismsPreparticipation screening (PPS) including personal/family history, physical exam, resting ECG, submaximal exercise testing with ECG monitoring, and second line evaluations
Target PopulationCompetitive athletes across age spectrum (children to middle age)
Care SettingSports medicine centers within private healthcare system

Key Highlights

  • 7.6% of athletes required second line cardiovascular evaluation after initial PPS
  • 0.34% of PPS exams identified high-risk cardiovascular conditions, increasing with age
  • Considerable variability in abnormal ECG rates among physicians (0% to 7.1%) and age-dependent screening costs

Guideline-Based Recommendations

Diagnosis

  • PPS should include structured personal and family history, physical examination, resting 12-lead ECG, and submaximal exercise testing with continuous ECG monitoring
  • Second line evaluations (echocardiography, bicycle ergometry, 24-hour Holter monitoring) for athletes with suspicious findings on PPS

Management

  • Referral for additional third line testing when diagnostic uncertainty persists after PPS and second line evaluation

Monitoring & Follow-up

  • Continual reevaluation of PPS practices to ensure clinical benefit and resource optimization

Risks

  • Variability in screening interpretation and diagnostic yield may affect accuracy
  • Uncertain sensitivity and specificity of individual PPS components due to lack of linked diagnostic data

Patient & Prescribing Data

Competitive athletes aged ≤18 years to ≥35 years undergoing PPS in Italy

Screening yield and costs increase with age; basic clinical evaluation components contribute substantially to abnormal findings though their diagnostic value is unclear

Clinical Best Practices

  • Implement structured PPS protocols including history, physical exam, ECG, and exercise testing
  • Use second line cardiovascular testing selectively based on initial PPS findings
  • Recognize variability in physician interpretation and strive for standardized training
  • Continuously collect and analyze real-world data to refine screening strategies
  • Consider cost-effectiveness and resource utilization in designing PPS programs

References

Original Source(s)

Related Content